Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Autor: Stanchi, Karin Melanie Cabanillas, Willier, Semjon, Vek, Julia, Schlegel, Patrick, Queudeville, Manon, Rieflin, Nora, Klaus, Veronika, Gansel, Melanie, Rupprecht, Joachim Vincent, Flaadt, Tim, Binder, Vera, Feuchtinger, Tobias, Lang, Peter, Handgretinger, Rupert, Döring, Michaela

Publikováno v: Drug Design, Development & Therapy; Sep2020, Vol. 14, p3915-3927, 13p

Antiemetic Prophylaxis with Fosaprepitant and 5-HT 3 -Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Autor: Cabanillas Stanchi KM; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Willier S; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. Von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany., Vek J; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Schlegel P; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Queudeville M; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Rieflin N; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Klaus V; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Gansel M; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Rupprecht JV; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Flaadt T; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Binder V; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. Von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany., Feuchtinger T; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. Von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany., Lang P; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Handgretinger R; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany., Döring M; Department of General Pediatrics, Hematology/Oncology, University Children's Hospital Tübingen, Tübingen, Germany.

Publikováno v: Drug design, development and therapy [Drug Des Devel Ther] 2020 Sep 25; Vol. 14, pp. 3915-3927. Date of Electronic Publication: 2020 Sep 25 (Print Publication: 2020).